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Abstract
Toll-like receptors (TLRs) are important for the host immune response to a variety 
of pathogens, including bacteria, viruses, fungi, and parasites. These receptors 
become activated upon recognizing pathogen-associated molecular patterns (PAMPs) 
and thus initiate the innate immune response to the corresponding pathogen. A key 
aspect of TLRs is their activation of signaling that leads to cytokine production and 
an inflammatory response. Additionally, TLRs act as the bridge between innate and 
acquired immunity, enhancing phagocytosis and the process of killing parasites. We 
herein focus on how parasites (protozoans and helminths) and their derived prod-
ucts have the capability of stimulating or evading the host response by triggering or 
inhibiting TLR activation. Parasites often develop successful survival strategies that 
imply interference with the host immune response. Accordingly, many of these organ-
isms have molecules that modulate inflammation and other aspects of host immunity. 
Taking advantage of such mechanisms, there are some anti-inflammatory therapies 
based on human infection with helminths. Helminths and protozoans influence the 
activity of various TLRs, especially TLR2, TLR4, and TLR9. A better understanding 
of the role of TLRs and their parasite-derived ligands should certainly provide new 
therapeutic tools for combatting various parasitic and inflammatory diseases.
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1. Introduction
Toll-like receptors (TLRs) have the important function of recognizing a variety 
of pathogens, including bacteria, viruses, fungi, and parasites. They recognize 
pathogen-associated molecular patterns (PAMPs) and consequently initiate the 
innate immune response. The well-known TLRs that are responsible for binding to 
PAMPs act as a bridge between innate and acquired immunity. Accordingly, they are 
not only involved in the production of cytokines and chemokines but also enhance 
phagocytosis and the process of killing parasites.
Parasites are organisms that live on or inside an organism and benefit by deriving 
nutrients at the expense of the host. We herein review how protozoan and helminth 
parasites trigger differential activation of TLRs in order to regulate host immune 
cells. In some cases, the activation of these TLR receptors by PAMPs contributes 
to an effective control of the infection, while in other cases there is a negative 
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regulation resulting in the exacerbation of the infection, as shown in distinct 
in vivo animal models. In patients with diverse clinical manifestations of parasitic 
infections, TLRs and cytokines play a key role in the host response to the disease. A 
better understanding of the role of TLRs and their ligands should certainly provide 
new therapeutic tools and perhaps allow for the development of vaccines to control 
parasitic infections.
2. Protozoan parasites
Among the many protozoan parasites, those presently examined are Leishmania 
spp., Trypanosoma spp., Naegleria fowleri, Plasmodium spp., Toxoplasma gondii, 
Giardia lamblia, Entamoeba histolytica, Trichomonas vaginalis, Blastocystis spp., and 
Acanthamoeba spp.
2.1 Leishmania spp.
Leishmaniasis, an infectious disease endemic in 88 countries representing 5 conti-
nents, is caused by parasitic protozoa in the genus Leishmania [1]. This parasite gives 
rise to a variety of disorders, ranging from cutaneous lesions to visceral disease [2]. 
The latter can be generated by Leishmania donovani, L. infantum, and L. chagasi [3].
Regarding cutaneous lesions, the most pathogenic agents of American cutane-
ous leishmaniasis in Brazil are L. (Viannia) braziliensis and L. (L.) amazonensis, 
capable of inducing localized cutaneous leishmaniasis, borderline disseminated 
cutaneous leishmaniasis, anergic diffuse cutaneous leishmaniasis, and mucosal 
leishmaniasis [4]. In Mexico, L. mexicana evokes a wide spectrum of cutaneous 
diseases. For instance, localized cutaneous leishmaniasis is characterized by ulcers 
at the site of parasite inoculation, while parasites in diffuse cutaneous leishmaniasis 
spread throughout the skin and form disfiguring nodules [5]. In Iran, cutaneous 
leishmaniasis is endemic in 18 of 31 provinces, and approximately one-fifth of the 
cases belong to anthroponotic cutaneous leishmaniasis, stemming from L. tropica 
[6]. L. panamensis, a member of the Viannia subgenus of Leishmania, is known to 
provoke mucosal leishmaniasis. It produces destructive lesions of the nasal, oral, 
and hypopharyngeal mucosa [1].
2.2 Trypanosoma spp.
The causal agent of Chagas disease, Trypanosoma cruzi, was first described by the 
Brazilian physician Carlos Chagas in 1909 [7]. This pathology is endemic in Central 
and South America, and evidence exists of some cases in the United States, Europe, 
and Japan due to travel and migration. The parasite is an intracellular protozoan of the 
Trypanosomatidae family, transmitted to humans by blood-feeding reduviid bugs.
There are two phases of Chagas disease. The acute phase is generally asymp-
tomatic, although some patients present symptoms such as fever, nausea, vomiting, 
anorexia, and diarrhea [8]. In the chronic phase, infected individuals can remain 
asymptomatic for decades, although around 30% eventually develop cardiac or 
gastrointestinal complications characteristic of the disease.
2.3 Other protozoans
Naegleria fowleri is a protozoan that invades the central nervous system and 
provokes primary amoebic meningoencephalitis. During the process of infection, it 
induces an important inflammatory response [9].
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Acanthamoeba spp. are free-living amoebae found in lakes, rivers, swimming 
pools, thermal baths, and tap water [10]. They infect humans and animals as 
opportunistic pathogens in immunocompromised hosts [11]. These parasites are 
able to generate severe diseases, including amebic Acanthamoeba keratitis, a painful 
sight-threatening infection of the cornea, and granulomatous amebic encephalitis, a 
fatal disease of the central nervous system.
Giardia lamblia, the causal agent of giardiasis, colonizes the lumen of the upper 
small intestine. The parasite adheres to the surface of enterocytes without traversing 
the enterocyte barrier [12].
P. falciparum, the protozoan parasite responsible for malaria, is transmitted 
by the bite of mosquitoes. It results in a wide spectrum of clinical manifestations 
during the vector-parasite-host interaction. The first asexual reproduction process 
occurs in the human liver [13].
Trichomonas vaginalis is a flagellated protozoan parasite that infects the human 
genitourinary tract. It is the causative organism of trichomoniasis, one of the most 
prevalent sexually transmitted diseases in the world [14].
Entamoeba histolytica, the etiologic agent of amebiasis, is a pathogenic enteric 
protozoan. The manifestations of the disease range from mild diarrhea to severe 
dysentery, with liver abscesses forming in rare cases [15].
Blastocystis, an enteric parasite, colonizes the colonic epithelia of human and 
animal hosts [16]. Infection with this parasite gives rise to diarrhea, abdominal pain, 
flatulence, vomiting, and bloating [17].
3. Helminth parasites
The word helminth is derived from the Greek “helmins,” which means parasite 
worm. Helminth is an umbrella term that includes many species of worms from 
different genera, having parasitism in common. They are quite frequently found in 
the population. The immune response depends largely on the type of parasite and 
its interaction with the host.
These large extracellular organisms have a complicated life cycle. They fre-
quently migrate through blood vessels and tissues until reaching the definitive 
organ, such as the intestine, lungs, liver, or lymphatic organs. Some invade and 
colonize various cell types.
Because helminths have developed strategies of evasion of the host immune 
response, they are often able to survive. Hence, they can weaken the immune 
response and survive for years in the infected host, establishing chronic infection 
[18]. When the host immune response is adequately activated, on the other hand, 
infections are eliminated quickly.
Fasciola hepatica is a trematode worm that mainly affects livestock (e.g., cows, 
sheep, and goats) and humans. It is transmitted through the ingestion of aquatic 
plants contaminated with metacercaria. Ascaris lumbricoides, a parasitic intestinal 
worm, is transmitted by ingesting water contaminated with embryonic eggs. 
Trichuris trichiura and T. suis, other species of intestinal worms, remain in the large 
intestine of mammals in the form of adult larvae. The infection occurs after the 
ingestion of the eggs, which hatch in the small intestine and release the infective 
larvae [19]. Schistosoma mansoni are larvae of worms that live in waters and ponds 
contaminated by feces. They are able to penetrate the skin of people who bath or 
swim in contaminated pools. In the adult stage, these parasites produce eggs that 
are excreted through the stool [20]. Strongyloides stercoralis is an infection generated 
by the larvae. These are acquired through the skin and later lodge themselves in the 
intestine. Trichinella spiralis is a parasitic nematode, which infects the muscle tissue 
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of practically all mammals. Toxocara canis, round worms found in dogs, can infect 
humans if ingested in the form of the infective eggs of Toxocara. The larvae migrate 
to the intestine, liver, or lungs.
4.  Molecules and protozoan and helminth parasites activate through 
TLRs
4.1 Leishmania spp. protozoans
L. major prompts the activation of the IL-1β promoter and mRNA expression in 
macrophages through the MyD88-pathway [21]. Additionally, L. major LPG upregu-
lates the expression of TLR2 in NK cells and the production of cytokines, such as 
IFN-γ, TNF-α, and nuclear factor NFκB [22].
Amastigotes from L. (V.) braziliensis reduce the expression of TLR4 on the 
membrane of macrophages. This receptor modulates the production of TNF-α and 
IL-10 [23]. L. infantum promastigotes stimulate the production of IFN-α/β in plas-
macytoid dendritic cells and the release of IL-12 by myeloid dendritic cells. Both 
these cytokines are dependent on TLR9 [24]. The expression of TLR9 and the 
production of TNF-α and IL-12 were observed in macrophages exposed to DNA 
from L. mexicana promastigotes [25]. Similarly, DNA from L. major was identi-
fied as the specific ligand that triggered TLR9-dependent activation of dendritic 
cells [26]. On the other hand, antigens of L. donovani stimulated the production 
of TNF-α, IL-12, and IFN-γ and increased TLR2 gene expression on RAW264.7 
macrophages [27].
L. panamensis infection upregulates the expression of TLR1, TLR2, TLR3, and 
TLR4 and the production of TNF-α in human primary macrophages [28]. In periph-
eral blood mononuclear cells, L. mexicana LPG fostered the production of TNF-α, 
IL-1β, IL-12 p40, IL-12 p70, and IL-10 and the expression of TLR2 and TLR4. The 
triggering of the latter TLRs led to phosphorylation of the extracellular regulated 
kinase (ERK) and p38 mitogen-activated protein kinase (MAPK) [29].
4.2 Other protozoans
Glycosylphosphatidylinositol (GPI), a molecule derived from trypomastigotes, 
was found to be a potent activator of TLR2 from human and mouse origin [30]. 
Another family of GPIs, glycoinositolphospholipid (GIPL), has been purified from 
epimastigotes and triggers NF-κB activation via TLR4 [31].
Whether the recognition of different GPI anchors is mediated by TLR2 or TLR4 
depends on their variable lipid moiety composition. There is one report of RA (high 
virulence) and K 98 (low virulence) strains of T. cruzi used to obtain total lipid 
extracts. The authors demonstrated that the total lipids from both strains promote 
the formation of lipid bodies and the release of pro-inflammatory molecules, 
including cyclooxygenase-2, TNF-α, and nitric oxide (NO) in macrophages as well 
as HEK cells, all through a TLR2/6-dependent pathway [32].
P. falciparum GPI contributes to the pathology of malaria by inducing the release 
of cytokines. In vitro studies have shown that this molecule is recognized by TLR2 
and to a lesser degree by TLR4 [33]. Hemozoin stimulates the production of IFN-γ 
and inflammatory cytokines by triggering TLR9 in dendritic cells [34].
T. vaginalis parasites enhance TLR2 gene expression and activate NOD-like 
receptor type 3 (NLRP3) inflammasome in mouse macrophages and THP-1 human 
macrophages, respectively [35]. They also regulate the production of pro-inflamma-
tory cytokines by the activation of MAPK and NFκB p65 and prompt pyroptotic cell 
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death through the release of IL-1β [36]. TLR4 upregulation has been reported in a 
prostate stromal cell line exposed to T. vaginalis [37].
Profiling like molecules and heat shock protein 70 from T. gondii activates dendritic 
cells through TLR4 and TLR11 [38]. The lipopeptidophosphoglycan (LPPG) and DNA 
from E. histolytica are recognized by TLR2, TLR4, and TLR9, triggering the release 
of IL-10, IL-12p40, TNF-α cytokines, and IL-8 from human monocytes [39, 40]. 
Unmethylated CpG oligodeoxynucleotides (CpG ODN) from the same parasite gener-
ate MMP-9 expression via the TLR9-dependent activation of ERK and p38 MAPK fol-
lowed by the activation of NFκB [41]. G. lamblia trophozoites trigger TLR2, resulting 
in the activation of ERK and MAPK and the production of pro-inflammatory cytokines 
in peritoneal macrophages of wild-type mice [42]. Live Blastocystis spp. parasites and 
whole cell lysate alone cannot trigger TLRs in THP-1 human monocytes. ST4WR1 para-
sites inhibit LPS-mediated activation of NF-κB in these same cells [43]. N. fowleri elicits 
the expression and production of pro-inflammatory cytokines and β-defensing-2, 
mainly through the canonical TLR4 pathway in a time-dependent manner [44].
4.3 Helminths
The host immune response mounted against helminth infections is activated 
through TLRs, which are triggered by the glycoproteins, secretion/excretion prod-
ucts, and various other molecules of the parasites [45].
Cathepsin cysteine  protease (FheCL1) of F. hepatica inhibits the secretion of 
various inflammatory mediators, such as TNF-α, IL-12, and NO [46]. This is carried 
out by the null activation of macrophages through the degradation of TLR3 in the 
endosome in a TRIF-dependent pathway independent of MyD88 [47]. Glucans pro-
mote the production of high levels of IL-10 and IL-4, thus favoring a Th2 response. 
These glycoconjugates modulate the function and maturation of dendritic cells. In 
the process of phase changes, Fasciola employs an immunosuppressive mechanism 
that favors a Th2 response [48], in part by releasing various excretory/secretory 
substances that inhibit the maturation of dendritic cells and trigger TLRs via the 
MyD88-dependent signaling pathway.
The excretory/secretory molecules of Taenia crassiceps initiate the phosphory-
lation of cRAF by means of MGL (lectins) and TLR2, as well as decreasing the 
maturation of dendritic cells and the production of IL-12 and TNF-α. These mol-
ecules also modulate the signaling pathways of NFκB p65 and p38 MAPK activated 
by LPS through TLR4 [49, 50] and regulate the type C receptor of lectin [51]. The 
carbohydrates of the parasite induce the production of IL-6 through TLRs [52].
On the other hand, the lysophosphatidylserine and lipopolysaccharide of A. lum-
bricoides generate signaling through TLR2, modulate a Th2 response (leading to the 
secretion of IL-10), and promote phosphorylation of ERK 1/2. This helminth binds 
to hyaluronic acid (the main constituent of connective tissue), activates dendritic 
cells by TLR4 (in adult parasites, or in larvae depending on the larval concentra-
tion), and provokes inflammatory processes. Through its antioxidant properties, it 
can eliminate free radicals and act as a barrier to tissue degradation.
Trichuris trichiura inhibits the function of TLR4 by suppressing LPS-induced 
production and the secretion of TNF-α [53]. Similarly, cathepsin B1 secreted by S. 
mansoni inhibits the recognition of TLR3 and TLR4 by inactivating the MyD88-
independent pathway and modulating Th2 responses. Phospholipids and glyco-
phosphatidylserine trigger TLR2 in dendritic cells, eliciting a Th2 response and the 
stimulation of Tregs to secrete IL-10.
The soluble antigen of S. mansoni suppresses the production of cytokines IL-1β, 
IL-6, IL-12, and TNF-α as well as increases the secretion of TGF-β and the produc-
tion of IL-10 in dendritic cells. Activated B cells augment the production of IL-10. 
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Both processes are dependent on the triggering of TLR2 and activation of MyD88, 
the latter of which promotes ERK1/2 phosphorylation [20]. dsRNA from S. mansoni 
binds to TLR3 in dendritic cells, thus positively regulating the expression of IFN 
type 1 genes [54–56].
Although the TLR4 receptor is not essential for killing the larva of S. stercoralis 
during the innate immune response, it is indeed crucial for killing the parasites 
during the adaptive immune response [57].
Phosphorylcholine is a glycoprotein released by T. spiralis that binds to TLR4 
[58]. Several TLRs decrease the susceptibility of effector T cells to Treg-mediated 
suppression [59]. During the first week of infection, the gene expression of TLR1, 
Figure 1. 
TLR activation by PAMPs of parasites.
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TLR2, TLR4, TLR5, and TLR9 increases significantly in the intestinal and muscular 
phases [60]. Infection also activates dendritic cells through TLR2 and TLR4 [61]. 
Since the TLR4/MyD88/NF-κB signaling pathway affects the secretion of inflam-
matory cytokines in macrophages, it may participate in immune suppression. In this 
sense, T. spiralis infection modulates the expression of TLR2 and TLR4 during dif-
ferent stages. Cytokine levels are regulated via TLR4-mediated signaling pathway, 
suggesting that TLR4 modulates host immunosuppression during infection [62].
Infection with Toxocara prompts cells to produce cytokines such as IL-4, IL-5, 
and IL-13, which generate increased IgE levels [63]. Toxocara canis inhibits the 
response of TLR2 to the activation of dendritic cells and competes with the host 
for lectins, thus blocking host immunity [64]. The activation of TLRs pathways by 
PAMPs of protozoans and helminths is summarized in Figure 1.
5. TLRs contribute to the effective control of parasite infection
5.1 Leishmania spp.
Infection by L. major in TLR4-deficient mice proliferates and correlates with 
a higher activity of arginase. In contrast, the same infection in TLR4-competent 
mice leads to low parasite replication that correlates with higher levels of inducible 
nitric oxide synthase. Hence, TLR4 competence could resolve cutaneous lesions and 
control parasite growth [65, 66].
TLR2 is unique among TLRs because it forms heterodimers with TLR1 or TLR6 
and modulates downstream signaling pathways. In peritoneal macrophages from 
BALB/c mice infected with L. major promastigotes, the expression of TLR1 and 
TLR2 increases but not that of TLR6. TLR2-TLR2 association increases but TLR2-
TLR6 association diminishes. The disparity in the formation of heterodimers 
between TLR2 and TLR1 or TLR2 and TLR6 brings about a TLR2 functional dual-
ity [67]. Additionally, LPG from L. major participates in the modulation of TLR9 
expression and function.
The question arises as to whether the functional duality of TLR2 contributes to such 
modulation. The co-administration of CpG and the anti-TLR2 antibody reduces infec-
tion in susceptible BALB/c mice, establishing a relationship between LPG, TLR2, and 
TLR9 during an L. major infection [27]. In C57BL/6 mice deficient in either TLR2, 4, or 
9, only the TLR9-deficient animals are more susceptible to infection with L. major. The 
deficiency of TLR9 inhibits the development of the curative Th1 response [26]. This effect 
has also been observed in TLR9-deficient mice infected with L. infantum. Therefore, 
TLR9 appears to play a key role in infections by L. major or L. infantum [2]. On the other 
hand, TLR11 and TLR12 play an important role in an L. major infection, evidenced by the 
fact that the silencing of these receptors reduces the parasite burden, enhances the level of 
IFN-γ, and diminishes the production of IL-4 [68].
Bone marrow-derived dendritic cells of MyD88−/− and TLR2−/− mice were 
infected with L. braziliensis. Compared to control mice, the infected dendritic cells 
from MyD88−/− mice showed low levels of activation and decreased production 
of cytokine IL-12p40, leading to greater infection by L. braziliensis and a limited 
expansion of CD4+ T cells that produce IFN-γ and IL-17 during infection. In con-
trast, TLR2−/− mice were more resistant to infection than control mice, which was 
associated with increased production of IFN-γ. Thus, MyD88 seems to be essential 
for the recognition of L. braziliensis, and TLR2 apparently has a regulatory role in 
modulating the immune response to the same parasite [69]. In peripheral blood 
mononuclear cells from cutaneous leishmaniasis patients infected with L. brazil-
iensis, an evaluation was made of the expression of co-stimulatory molecules CD80, 
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CD86, and TLR9. Monocytes decreased the expression of these co-stimulatory 
molecules, but their expression was higher when the cells were exposed to soluble 
Leishmania antigen [70].
In the spleen of mice infected with L. chagasi, possible correlations were ana-
lyzed between TLR2 and TLR4 mRNA expression and the production of cytokines 
and nitric oxide (NO). Whereas the mRNA expression of TLR2, TLR4, IL-17, TNF-
α, and TGF-β increases in the early stage of infection, it decreases during the late 
stage, which correlates with parasite load. The mRNA expression of IFN-γ and IL-12 
declines at the peak of infection [3].
On the other hand, mice with the A20 protein silenced (a protein that inhibits 
NFκB activation by modulating the function of IKK, TRAF6, and NEMO) were 
infected with L. donovan, finding enhancement of the activation of NFκB and the 
host-protective pro-inflammatory response (compared to normal mice), which 
correlates with effective parasite clearance [71].
5.2 Other protozoans
Single-nucleotide polymorphisms have a role in innate immune responses and 
in susceptibility/resistance to infection. However, the genetic association of TLR4 
and TNF-α polymorphisms is a determinant factor for the development of disease 
in Chagas disease. It has been reported the greatest parasite load exists in individu-
als with the C/C-Asp/Asp-Thr/Thr combination of homozygous genotypes at the 
TNF-α promoter 1031 and on the TLR4 polypeptide. The former homozygous 
genotype is represented by C/C. The latter homozygous genotypes encode Asp/Asp 
and Thr/Thr at codons 299 and 399, respectively [72]. Two TLR1 polymorphisms, 
rs4833095 (Asn248Ser) and rs5743618 (Ser602Ile), were assessed among 302 
primiparous Ghanaian women for their association with P. falciparum infection 
and placental malaria and susceptibility to placental malaria [73]. It was found that 
TLR4-Asp299Gly and the TLR4-Thr399Ile variants confer greater risk of severe 
malaria in Ghanaian children [74]. The single-nucleotide polymorphism of TLR6 
S249P may be a risk factor for the development of malaria [75]. Regarding TLR5, 
the single-nucleotide polymorphism of the TIR domain (TIRAP) S180 L provides 
protection against malaria, while the single-nucleotide polymorphism of R392 stop 
codon increases susceptibility to the same disease [76]. An rs4986790 polymor-
phism of the TLR4 gene can modulate the susceptibility toward a P. vivax infection. 
The AA genotype proved to be protective against the development of this parasite in 
a local population of Pakistan [77]. Additionally, TLR4 A299G, TLR6 S249, and TLR 
9-1486C/T influence the levels of circulating cytokines IL-6, IFN-γ, IL-12, IL-10, 
and IL-4 during a P. vivax infection [78].
Mice deficient in the adaptor protein MyD88 and IL-18 were more susceptible to 
P. yoelii infection and increased parasitemia during the early phase of the infection. 
Greater lethality was observed in the MyD88-deficient animals. In mice deficient 
in IL-1R, parasitemia showed a slight increment during infection with P. yoelii [79]. 
During infection with the same parasite, there was a high level of parasite burden in 
TLR2−/− mice, which was closely associated with a reduction in pro-inflammatory 
cytokines in the liver [80].
On the other hand, the TLR9 variant −1237C/C correlates with acute parasitemia 
during a P. vivax infection [81]. An endoplasmic reticulum resident protein, UNC93B1, 
is critical for host resistance to T. cruzi and T. gondii [80, 82]. Its function is the translo-
cation of nucleotide-sensing TLRs from the endoplasmic reticulum to endolysosomes. 
Interestingly, TLR2−/− and AKT-blocked mice that are infected with Giardia display 
a decreased parasite burden, an increased weight gain rate, and a shorter parasite 
persistence compared to normal mice infected with the same protozoan [42].
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5.3 Helminths
The immune responses against helminth infections do not efficiently protect the 
host. The immune system is unable to eliminate chronic infection, and the immune 
memory fails to protect against reinfection, even after a cure mediated by pharma-
cological treatment [83].
For an S. mansoni or A. lumbricoides infection, dendritic cells are fundamental in 
the protection and activation of host defensive responses. When TLR receptors on 
the surface of dendritic cells bind to the ligands of the S. mansoni, A. lumbricoides, and 
T. trichiura parasites, there is an increased expression of co-stimulatory molecules 
(CD40, CD80, and CD86) and synthesis of pro-inflammatory mediators, such as 
IL-12 and TNF-α, that evoke a Th1 lymphocyte response [84, 85]. For intestinal 
parasites, the mRNA expression of TLR1, TLR2, TLR3, TLR4, and TLR9 is regu-
lated in the early stages of infection. During the adult stage of an infection with 
T. spiralis, TLR1 and TLR4 activate the signaling pathway dependent on MyD88. 
Once newborn larvae appear, however, all expression of TLRs is inhibited, except 
for TLR2. The expression of TLR2/4 in the small intestine and muscle tissue during 
infection could be closely associated with immune responses mediated by Treg 
cells and greater expression of cytokines such as IL-10 and TGF-β [86, 87]. During 
an infection by S. mansoni, TLR2 and TLR4 limit the activation of the intestinal 
immune response. Consequently, the deficiency of these TLRs promotes the expul-
sion of adult worms. In the course of the first weeks of infection of animals with 
such deficiency, the expression of several TLRs increases, an active state that begins 
to decrease as of the fourth week. This favors an early activation of the immune 
response in the host and the prompt expulsion of the parasites [88].
6. Negative regulation by TLRs
6.1 Leishmania donovani, Giardia lamblia, and Schistosoma mansoni
L. donovani infection results in a suppression of TLR2- and TLR4-stimulated 
production of IL-12p40 and an increase in IL-10 production. Additionally, the 
parasites modulated the MAPK pathway by suppressing TLR2-dependent MAPK 
and ERK phosphorylation [89].
An in vitro infection with G. lamblia leads to a decreased production of pro-
inflammatory cytokines by activating the AKT signaling pathway via TLR2.
Helminths are regulated by the expression of soluble antigens, which in parasites 
such as S. mansoni and F. hepatica exert an inhibitory effect on the maturation of den-
dritic cells induced by TLR ligands. The dendritic cells activated by soluble antigens 
produce a smaller amount of IL-12 than those activated only with the ligand for TLR4 
[90–92]. The soluble antigen extracts of S. mansoni inhibit the ability of CpG, poly 
I:C, hyaluronic acid, and LPS to stimulate the production of IL-12 or increase the 
surface expression of CD80, CD86, and MHC class II in dendritic cells. Therefore, 
these extracts decrease the production of IL-12, IL-6, and TNF-α and the expression 
of co-stimulatory CD80/86 molecules, which in turn suppresses the Th1 response and 
favors the Th2 response elicited by LPS [93, 94]. The negative regulation of TLRs can 
reduce the production of pro-inflammatory cytokines, which could protect the host 
from autoimmune pathogenesis. The mechanism of this action is the regulation of 
the Th1/2 cell balance and the modulation of TLR4 expression [92, 95, 96].
In order to adapt to the immune system, some helminth parasites activate and/or 
downregulate TLRs, as well as interfere with the expression of several genes related 
to the transduction pathway [86]. Several studies suggest that continuous exposure 
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to helminth antigens may negatively regulate the response of cells to PAMPs derived 
from these parasites, implying a weakened immune response in individuals infected 
with helminths.
6.2 Highly virulent parasites downregulate TLR expression
According to an in vitro assay, T. cruzi strains with low virulence cause relatively 
high expression of TLR4 and high levels of pro-inflammatory cytokines such as 
IL-12 and TNF-α. Contrarily, virulent T. cruzi strains maintain a low expression of 
TLR4 and reduced production of TNF-α [97]. Likewise, at 2 days post-infection with 
Acanthamoeba strains Ac55 and Ac43, the mRNA expression of TLR2 and TLR4 was 
elevated in the brain of mice (versus control animals) [98]. Compared to uninfected 
mice, moreover, Acanthamoeba sp. generated a high expression of the mRNA and high 
levels of TLR2 in the brain of animals at 2, 4, 8, 16, and 30 days post-infection [99].
7. TLRs in the outcome of disease
7.1 Leishmaniasis
Splenic biopsies and peripheral blood samples (to obtain mononuclear cell isolates) 
were taken from patients with visceral leishmaniasis in India, detecting the mRNA 
expression of TLR2 and TLR4 but not TLR9. The mRNA expression of IL-10 and IFN-γ 
was greater in pre-treatment versus posttreatment splenic biopsies. Additionally, the 
levels of IFN-γ and IL-10 mRNA were higher in peripheral blood mononuclear cells for 
pre-treatment versus posttreatment patients and healthy controls [100].
In Brazil, the peripheral blood mononuclear cells and lymphocytes (CD14+ and 
CD3+) were analyzed in 13 patients diagnosed with visceral leishmaniasis before 
and after treatment. Compared to healthy controls, there was a greater expression 
before treatment of TLR2 and TLR4 in lymphocytes and monocytes. Additionally, 
the levels of TNF-α, IL-10, and TGF-β increased, and those of IFN-γ, IL-17, and 
NO decreased. Although the expression of these two receptors did not change in 
lymphocytes after treatment, in monocytes they were found to be lower for TNF-α 
and IL-10 and higher for TGF-β, IFN-γ, IL-17, and NO [101].
Samples of whole blood taken from patients in Eastern Sudan with visceral leish-
maniasis were stimulated with live L. donovani promastigotes. The expression of 
TLR2, TLR4, and TLR9 was found, which correlated with the production of IFN-γ, 
TNF-α, and IL-10 [102]. Similarly, the expression of TLR2 and TLR4 was measured 
in peripheral blood mononuclear cells of patients with cutaneous leishmaniasis, 
both those with healing and non-healing wounds, observing a significantly greater 
level in the macrophages of individuals with the healing versus non-healing lesions. 
This suggests a possible role of TLR2 and TLR4 in the outcome of cutaneous leish-
maniasis lesions [103].
It is known that L. (V.) braziliensis and L. (L.) amazonensis interact with these 
same TLRs to promote a differential T-cell immune response and cytokine expression 
in mucosal leishmaniasis and anthroponotic cutaneous leishmaniasis. Biopsies taken 
from skin and mucosal lesions of infected patients were examined by immunohis-
tochemistry, finding an important expression of TLR2, TLR4, and TLR9. Whereas 
tissues associated with L. (V.) braziliensis exhibited strong expression of TLR2 and 
TLR4, those tissues linked to L. (L.) amazonensis displayed similar results in rela-
tion to TLR9. The greatest expression of CD4+ T cells was encountered in mucosal 
leishmaniasis and the lowest in anergic diffuse cutaneous leishmaniasis. Similarly, 
CD8+ T cells showed their lowest expression in the latter disorder compared to the 
11
TLR-Mediated Host Immune Response to Parasitic Infectious Diseases
DOI: http://dx.doi.org/10.5772/intechopen.84679
other forms of the disease. There was greater expression of TNF-α in anergic diffuse 
cutaneous leishmaniasis versus mucosal leishmaniasis and of IL-10 and TGF-β in 
mucosal leishmaniasis versus anergic diffuse cutaneous leishmaniasis [4].
Although NK cells are detected in individuals infected with L. mexicana and 
suffering from localized cutaneous leishmaniasis as well as diffuse cutaneous 
leishmaniasis, the number of cells and the effector mechanisms differed drastically 
between the two groups. The number of NK cells, production of IFN-γ and TNF-α, 
and expression of TLR2, TLR1, and TLR6 were all lower than normal in patients 
with diffuse cutaneous leishmaniasis while being normal in those with localized 
cutaneous leishmaniasis. The altered protein expression found in NK cells of the 
former group correlated with the downregulation of IFN-γ gene expression in 
LPG-stimulated and non-stimulated cells. In conclusion, the lower number of NK 
cells and their limited activity in individuals with diffuse cutaneous leishmaniasis, 
evidenced by reduced TLR expression and cytokine production, are likely involved 
in the severity of the disease [5].
Peripheral blood was taken from patients with anthroponotic cutaneous leish-
maniasis, including those responsive and unresponsive to treatment as well as 
healthy controls. Some mononuclear cells from these blood samples were exposed to 
L. tropica and others unexposed. An evaluation was made of the gene expression of 
TLR2, TLR4, TLR9, and TNF-α and the activity of iNOS and arginase in monocytes 
from patients unresponsive and responsive to Glucantime treatment. Upon com-
paring the monocytes exposed and unexposed to L. tropica, the former exhibited 
greater expression of all three TLRs and TNF-α and lower expression of iNOS in 
both groups of patients (responsive and unresponsive to treatment). Additionally, 
there was a significant downregulation of TLR2 and TNF-α expression and upregu-
lation of TLR9 expression in isolates from unresponsive versus responsive individu-
als. Isolates from the former group also showed a significant increase in the level of 
arginase in monocytes stimulated with L. tropica and cultured promastigotes [6].
7.2 Chronic chagasic cardiomyopathy (CCC)
Chagas disease has different clinical forms: indeterminate, digestive, and 
cardiodigestive. CCC is associated with greater expression of TLR2, IL-12, and 
TNF-α. However, the expression of MyD88 mRNA is greater in cardiodigestive 
than indeterminate and cardiac patients. Serum mRNA expression of IL-12 and 
TNF-α transcripts was found in cardiac patients, who showed a higher production 
of TLR-induced inflammatory cytokines (TNF-α and IL-12) than indeterminate 
patients and uninfected individuals. Digestive and cardiodigestive clinical cases are 
correlated with elevated mRNA expression of TLR8 and IFN-β [104].
7.3 Helminth infections
During the interaction of S. mansoni with the host immune system, TLR4 activa-
tion provides a protective role against infection, while TLR2 activation is favorable 
for the parasite. The gene expression of the TLRs 1, 3, 7, and 8 is suppressed after 
infection. The antigens of A. lumbricoides promote the expression of TLR2 and thus 
engender a Th2 response [105–108].
8. Role of TLRs in strategies for the control of parasitic infections
TLRs have potential as therapeutic targets, either alone or in combination with 
conventional immunotherapy and pharmacotherapy. In recent years, antagonists 
Toll-like Receptors
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of TLRs or agonists of their negative regulators have been investigated as vaccine 
adjuvants to enhance an effective immune response against tumors, allergies, and 
infectious diseases [109].
The vaccine adjuvant properties of TLR7 and/or TLR8 agonists imiquimod and 
R848 were tested in the model of infection by L. major, determining the immune 
response before and after infection. Protective immunity was generated following 
subcutaneous but not intramuscular vaccination [110]. In another study, the effect 
of L. major polyclonal anti-murine TLR2 and TLR4 antibodies was assessed on 
cutaneous leishmaniasis and inflammatory arthritis. Both antibodies suppressed 
the development of clinical parameters, accompanied by reduced pro-inflammatory 
cytokine production. Hence, anti-TLR2 and TLR4 antibodies possibly have a syner-
gistic therapeutic effect on inflammatory disease [111].
In visceral leishmaniasis, evaluation was made of anti-Leishmania immune 
responses. The protective efficacy of the glycosphingophospholipid (GSPL) antigen 
of L. donovani parasites when acting as a ligand for β-(1-4)-galactose terminal NKT 
cells suggests an important role of TLR4. This receptor may function as an upstream 
sensor by GSPL and induce the intracellular inflammatory signaling necessary for 
killing parasites. Treatment with GSPL was able to cause a highly effective T-cell 
response that contributed to good control of infection. Therefore, the synergism 
of TLR4 and NKT cells prompted GSPL to evoke a host-protective immunological 
response in experimental visceral leishmaniasis [112].
The collateral effects of a malaria infection during pregnancy correlate with 
immune activation in placental tissue. Since TLR4 plays a key role in this process, 
its blockage could be a potential strategy for therapeutic intervention to reduce the 
incidence of malaria-induced pathology both in the mother and the fetus [113].
Skin scarification with the P. falciparum peptide vaccine in combination with a 
TLR agonist produces systemic neutralizing antibodies with the potential of block-
ing parasite egress from the skin (and thus avoiding the invasion of liver cells) [114].
A good adjuvant formulation is crucial in the development of a successful 
vaccine. In the amebiasis model, the nanoliposome adjuvant containing synergistic 
TLR4 and TLR7/8 agonists successfully elicited balanced systemic humoral and 
cellular immune responses. The immunization protected against infection with up 
to 55% efficacy [115].
Since helminths use various molecules to regulate the host immune response, 
some of these may have potential therapeutic action against allergies and other 
inflammatory diseases. This anti-inflammatory strategy has been successful in 
treating diseases in animal models. Helminth-derived molecules are potent immu-
nomodulators that could possibly be used for the design of new anti-inflammatory 
drugs. For example, the nematodes T. suis and T. spiralis induce a significant sup-
pression of symptoms in autoimmune encephalomyelitis, an animal model validated 
for multiple sclerosis. Therefore, infection with live nematodes is not a prerequisite 
for the suppression of inflammation [53, 116].
Crohn’s disease and ulcerative colitis are closely related to inflammatory pro-
cesses. Some therapies, such as the ingestion of eggs of T. suis, promote a TLR2- and 
TLR4-regulated decline in inflammatory activity as well as a reduction in adverse 
effects of inflammation. This is based on the ability of helminths to polarize the 
response of helper T cells to a Th2 type, which inhibits inflammation. F. hepatica, on 
the other hand, exerts influence on dendritic cells activated by CpG, thus fostering 
the development of Tregs and a decrease in the severity and incidence of the disease 
[117]. S. mansoni alleviates allergies and reduces inflammation in airways.  
A. suum diminishes ocular allergic disease and T. spiralis, by evoking a Th2 response, 
and inhibits the production of IFN-γ to relieve colitis. These results are interest-
ing because they demonstrate the interference of a helminth infection with the 
13
TLR-Mediated Host Immune Response to Parasitic Infectious Diseases
DOI: http://dx.doi.org/10.5772/intechopen.84679
establishment of an inflammatory immune response that favors other pathologies 
[118]. The aforementioned evidence of helminths regulating the immune response 
through TLRs could be instrumental in the development of therapeutic targets 
as well as in the inhibition or stimulation of their expression. Further research is 
needed to clarify the potential role of helminths in the modulation of the inflamma-
tory response.
9. Conclusion
TLRs, one of the best characterized families of receptors, have a critical role 
in the host defense against infection. Additionally, they play a key role in the 
capacity of different protozoans and helminths to be able to generate a continuous 
activation of the host immune system by modulating the elements of the innate 
and/or adaptive response. Such intervention by these parasites in the immune 
response is aimed at promoting their survival inside the host. Single-nucleotide 
polymorphisms in TLRs participate importantly in increasing parasitemia in the 
host. However, agonists of TLRs can have a dual role. Whereas they may serve as 
adjuvants or vaccines to promote the maturation of dendritic cells and thus induce 
an adaptive immune response, they are also capable of triggering inflammatory 
cytokine production that has a pathogenic role in many diseases. Consequently, 
antibodies to TLRs and inhibitors of TLR signaling pathways have considerable 
potential as therapeutic agents. It is still necessary to clarify their mechanisms 
for modulating the response of these receptors to be able to design and develop 
innovative therapeutic targets.
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